seasonal allergic rhinitis
Conditions
Interventions
From the first medical examination, administer 10mg as bepotastine besilate twice a day orally for 2-3 weeks.
Upon clinical symptoms after first medical treatment, switch to bepotastine besilate 10m
Sponsors
Juntendo University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with Japanese cedar or cypress pollinosis
Exclusion criteria
Exclusion criteria: (1) Patient that change of symptom is remarkable after specific immunotherapy is begun. (2) Patient who should continuously use medicine (steroid drugs,immunosuppressive drugs and others) that influences when effect of drug evaluation. (3)Severity dyshepatia and dysnephria patient. (4) Pregnancy, potential pregnancy, and breast-feeding patient. (5) the others, inappropriate to this study by the judgment of doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alteration of nasal symptom and ocular condition of four weeks and eight weeks after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom score (stuffy nose,runny nose, sneezing,eye itchiness and tearing), medication score and QOL Questionaire score(JRQLQ No1). | — |
Countries
Japan
Contacts
Public Contactmasato miwa
Juntendo University Otorhinolaryngology
Outcome results
None listed